Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Total remimazolam plasma concentrations in cardiovascular surgery under cardiopulmonary bypass
jRCT1051230163Recruiting
- Sponsor
- Motoi Inoue
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of remimazolam in cardiac morbidity, sponsored by Motoi Inoue. Primary endpoint: Total remimazolam plasma concentrations. Started Jan 2024; status: recruiting.
02
Drugs
remimazolam
03
Conditions
cardiac morbidity
Beyond the preview
Go deeper on jRCT1051230163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051230163.